Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hansoh Pharmaceutical Group Company Limited ( (HK:3692) ) has provided an announcement.
Hansoh Pharmaceutical Group Company Limited announced a rescheduling of dates related to its interim dividend for the six months ended June 30, 2025, due to unstable weather conditions. The changes affect the timeline for lodging transfer documents, the book closure period, and the record date, but the payment date remains unchanged. This adjustment ensures the company maintains its operational commitments despite external challenges.
The most recent analyst rating on (HK:3692) stock is a Hold with a HK$37.00 price target. To see the full list of analyst forecasts on Hansoh Pharmaceutical Group Company Limited stock, see the HK:3692 Stock Forecast page.
More about Hansoh Pharmaceutical Group Company Limited
Hansoh Pharmaceutical Group Company Limited is a pharmaceutical company incorporated in the Cayman Islands. It operates in the healthcare industry, focusing on the development, manufacturing, and marketing of pharmaceutical products.
Average Trading Volume: 12,714,650
Technical Sentiment Signal: Buy
Current Market Cap: HK$214.1B
Find detailed analytics on 3692 stock on TipRanks’ Stock Analysis page.